產(chǎn)品英文名稱：RosetteSep™ Human Circulating Epithelial Tumor Cell Enrichment Cocktail
產(chǎn)品中文名稱：RoboSep™ 人循環(huán)上皮性腫瘤細(xì)胞富集混合物

RosetteSep™ Human Circulating Epithelial Tumor Cell Enrichment Cocktail 產(chǎn)品英文描述
The RosetteSep™ Human Circulating Epithelial Tumor Cell Enrichment Cocktail is designed to enrich circulating epithelial tumor cells from fresh whole blood by negative selection. Unwanted cells are targeted for removal with Tetrameric Antibody Complexes recognizing CD3, CD14, CD16, CD19, CD38, CD45, CD56, CD61, CD66b and glycophorin A on red blood cells (RBCs). When centrifuged over a density gradient medium such as Lymphoprep™ (Catalog #07801), the unwanted cells pellet along with the RBCs. The purified tumor cells are present as a highly enriched population at the interface between the plasma and the density gradient medium.

RosetteSep™ Human Circulating Epithelial Tumor Cell Enrichment Cocktail 產(chǎn)品組分
RosetteSep™ Human Circulating Epithelial Tumor Cell Enrichment Cocktail

RoboSep™ 人循環(huán)上皮性腫瘤細(xì)胞富集混合物推薦使用
The isolation of human circulating epithelial tumor cells from whole blood by negative selection

RosetteSep™ Human Circulating Epithelial Tumor Cell Enrichment Cocktail 保存方法
RosetteSep® Human Circulating Epithelial Tumor Cell Enrichment Cocktail.
Stable at 4°C for two years. Do not freeze this product. Contents sterile in unopened tube.This product may be shipped at room temperature, and should be refrigerated upon receipt.

RosetteSep™ Human Circulating Epithelial Tumor Cell Enrichment Cocktail 實驗資料
FACS Profile Results With RosetteSep® Human Circulating Epithelial Tumor CellEnrichment Cocktail

RosetteSep™ Procedure


RoboSep™ 人循環(huán)上皮性腫瘤細(xì)胞富集混合物相關(guān)產(chǎn)品訂購信息
Stemcell  10417  CD45 Antibody, Clone 2D1, FITC-Conjugated  Mouse Monoclonal Antibody to Human CD45 - FITC Conjugated 
Stemcell  07801  Lymphoprep™  Density Gradient Medium for the Isolation of Mononuclear Cells                
For research use only. Not intended for human or animal diagnostic or therapeutic uses.